
|Articles|July 1, 2004
- Volume 0 0
Chlamydia and Infertility Are Linked
Advertisement
A Swedish study has identified for the first time a link between chlamydia infection and male infertility. The study of 244 couples, reported in Human Reproduction (May 2004), found decreased pregnancy rates in couples where men had IgG antibodies. These antibodies act as a marker of previous or persistent chlamydia infection. The results showed that, if a man was IgG-positive, the couple's chance of achieving pregnancy was lowered by 33%. The researchers recommended that testing for IgG in both men and women should be part of routine infertility examinations.
Articles in this issue
over 22 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 22 years ago
Research Links Diabetes with Alzheimer'sover 22 years ago
Individuals with Chronic Pain Keep Quietover 22 years ago
Association Redesigns Web Siteover 22 years ago
Fibromyalgia Hits Individuals Differentlyover 22 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesover 22 years ago
Europeans Are Slow to Seek Treatmentover 22 years ago
Intervention Curbs Asthma in Childrenover 22 years ago
Vaccine at Birth May Diminish Allergiesover 22 years ago
Asthma in Women Is Greater with Acetaminophen UseAdvertisement
Related to this article

BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.

A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.

Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.

American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.

fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.

Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.

A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
Advertisement
Advertisement

